Circulating cytokines and angiogenic factors (CAFs) in patients with advanced non-clear cell renal cell carcinoma treated with sunitinib: Results from a phase II clinical trial

被引：0
|
作者：
Bilen, Mehmet Asim [1 ]
Zurita, Amado J. [1 ]
Ilias-Khan, Nasreen A. [1 ]
Chen, Hsiang-Chun [1 ]
Wang, Xuemei [1 ]
Hodges, Sherie [1 ]
Lim, Zita D. [1 ]
Jonasch, Eric [1 ]
Khakoo, Aarif Yusuf [1 ]
Tannir, Nizar M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.483
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
483
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
    Koshkin, Vadim S.
    Barata, Pedro C.
    Zhang, Tian
    George, Daniel J.
    Atkins, Michael B.
    Kelly, William J.
    Vogelzang, Nicholas J.
    Pal, Sumanta K.
    Hsu, JoAnn
    Appleman, Leonard J.
    Ornstein, Moshe C.
    Gilligan, Timothy
    Grivas, Petros
    Garcia, Jorge A.
    Rini, Brian I.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [32] Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma
    Heng, Daniel Y. C.
    Bukowski, Ronald M.
    ONCOLOGY REVIEWS, 2007, 1 (03) : 170 - 176
  • [33] Results of a phase II study of atezolizumab and bevacizumab in non-clear cell renal cell carcinoma (nccRCC) and clear cell renal cell carcinoma with sarcomatoid differentiation (sccRCC).
    Mckay, Rana R.
    McGregor, Bradley Alexander
    Gray, Kathryn
    Steinharter, John A.
    Walsh, Meghara K.
    Braun, David A.
    Flaifel, Abdallah
    VanAllen, Eliezer
    Wei, Xiao X.
    Signoretti, Sabina
    Harshman, Lauren Christine
    Vaishampayan, Ulka N.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [34] Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial
    Barata, Pedro C.
    Chehrazi-Raffle, Alexander
    Allman, Kimberly D.
    Asnis-Alibozek, Aviva
    Kasturi, Vijay
    Pal, Sumanta K.
    ONCOLOGIST, 2023, 28 (10): : 894 - 900
  • [35] Comprehensive analysis of survival outcomes in non-clear cell renal cell carcinoma patients treated on clinical trials
    De Velasco, Guillermo
    Mckay, Rana R.
    Lin, Xun
    Moreira, Raphel B.
    Simantov, Ronit
    Choueiri, Toni K.
    BJU INTERNATIONAL, 2016, 118 : 12 - 12
  • [36] Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials
    de Velasco, Guillermo
    Mckay, Rana R.
    Lin, Xun
    Moreira, Raphel B.
    Simantov, Ronit
    Choueiri, Toni K.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : 652 - +
  • [37] Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial (vol 86, pg 90, 2024)
    Fitzgerald, Kelly N.
    Lee, Chung-Han
    Voss, Martin H.
    Carlo, Maria I.
    Knezevic, Andrea
    Peralta, Laura
    Chen, Yingbei
    Lefkowitz, Robert A.
    Shah, Neil J.
    Owens, Colette N.
    Mchugh, Deaglan J.
    Aggen, David H.
    Laccetti, Andrew L.
    Kotecha, Ritesh R.
    Feldman, Darren R.
    Motzer, Robert J.
    EUROPEAN UROLOGY, 2025, 87 (01) : 96 - 96
  • [38] Phase II, Multicenter, Uncontrolled Trial of Single-agent Capecitabine in Patients With Non-clear Cell Metastatic Renal Cell Carcinoma
    Tsimafeyeu, Ilya
    Demidov, Lev
    Kharkevich, Galina
    Petenko, Natalia
    Galchenko, Vladimir
    Sinelnikov, Igor
    Naidzionak, Uladzislau
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (03): : 251 - 254
  • [39] Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study
    Vogelzang, Nicholas J.
    Olsen, Mark R.
    McFarlane, Joshua J.
    Arrowsmith, Edward
    Bauer, Todd M.
    Jain, Rohit K.
    Somer, Bradley
    Lam, Elaine T.
    Kochenderfer, Mark D.
    Molina, Ana
    Doshi, Gurjyot
    Lingerfelt, Brian
    Hauke, Ralph J.
    Gunuganti, Vijay
    Schnadig, Ian
    Van Veldhuizen, Peter
    Fleming, Mark
    Galamaga, Robert
    Gupta, Mukul
    Hool, Hugo
    Hutson, Thomas
    Zhang, Joshua
    McHenry, M. Brent
    Johansen, Jennifer L.
    Tykodi, Scott S.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : 461 - +
  • [40] Phase 2 study of combination tivozanib and nivolumab in advanced non-clear cell renal cell carcinoma (RCC): FORTUNE trial
    Nguyen, Charles B.
    Vaishampayan, Ulka N.
    Campbell, Matthew T.
    Hammers, Hans J.
    Brooks, Roserika
    Solley, Travis
    Wood, Lauren Michelle
    Jonasch, Eric
    Alva, Ajjai Shivaram
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345